Cited by 70Parkinson's Disease Mechanisms and TreatmentsTelomeres, Telomerase, and SenescenceDementia and Cognitive Impairment Research

Telomere length in Parkinson's disease: A meta-analysis

Open access
Forero, Diego A., González-Giraldo, Yeimy, López-Quintero, Catalina, Castro-Vega, Luis J., Barreto, George E., Perry, George·2016·Experimental Gerontology

Abstract

Parkinson's disease (PD) is a common and severe movement disorder. Differences in telomere length (TL) have been reported as possible risk factors for several neuropsychiatric disorders, including PD. Results from published studies for TL in PD are inconsistent, highlighting the need for a meta-analysis. In the current work, a meta-analysis of published studies for TL in PD was carried out. PubMed, Web of Science and Google Scholar databases were used to identify relevant articles that reported TL in groups of PD patients and controls. A random-effects model was used for meta-analytical procedures. The meta-analysis included eight primary studies, derived from populations of European and Asian descent, and did not show a significant difference in TL between 956 PD patients and 1284 controls (p value: 0.246). Our results show that there is no consistent evidence of shorter telomeres in PD patients and suggest the importance of future studies on TL and PD that analyze other populations and also include assessment of TL from different brain regions.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.exger.2016.01.002

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • There is no clear evidence of telomere length changes in Parkinson's disease patients.

    “Although there is no clear evidence of telomere length changes in patients with Parkinson’s disease170”

    From Telomere dysfunction in ageing and age-related diseases (2022) · cites this paper as [170]

  • There is no difference in telomere length between PD patients and age-matched controls.

    “A meta-analysis by Forero et al., incorporating all these studies, showed that there is no difference in telomere length between PD patients and age-matched controls [270].”

    From Ageing, Cellular Senescence and Neurodegenerative Disease (2018) · cites this paper as [270]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 23 · Cited by 70

Authors
Forero, D. A., González-Giraldo, Y., López-Quintero, C., Castro-Vega, L. J., Barreto, G. E., & Perry, G.
Affiliations
  • Universidad Antonio Nariño (CO)
  • Pontificia Universidad Javeriana (CO)
  • The University of Texas at San Antonio (US)
Corresponding author
Forero, Diego A.
Venue
Experimental Gerontology
Publisher
Elsevier BV
Published
2016-03
Volume
75
Pages
53-55
ISSN
0531-5565 (ISSN-L)
OpenAlex
W2225243193
Cited by
70
References
23
Citations by year
2026: 2 · 2025: 11 · 2024: 4 · 2023: 6 · 2022: 7 · 2021: 9 · 2020: 10 · 2019: 6 · 2018: 8 · 2017: 3 · 2016: 4
FWCI
0.97
Type
journal article
Language
en
Open access
Locations
  • Experimental Gerontology (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • Colciencias (20131079, 20131080)
  • VCTI-UAN
  • Centro de Estudios Interdisciplinarios Básicos y Aplicados
  • National Institute on Drug Abuse (T32DA021129)
  • Pontificia Universidad Javeriana
  • NIH (G12-MD007591)
Topics
  • Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
  • Health Sciences › Medicine › Physiology › Telomeres, Telomerase, and Senescence
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords
Parkinson's disease, telomere length, telomere shortening, aging, neurodegeneration, biomarkers, brain regions
MeSH terms
Humans, Parkinson Disease, Risk Factors, Case-Control Studies, Telomere, Telomere Shortening

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review